Clinical Evidence: What Healthcare Professionals Say
BNF Classification and Clinical Standing
According to the British National Formulary, sildenafil belongs to the phosphodiesterase type-5 inhibitor class, representing the gold standard for erectile dysfunction treatment. The BNF recognises sildenafil's mechanism of action - selectively inhibiting PDE5 to enhance nitric oxide-mediated smooth muscle relaxation in penile blood vessels. This clinical understanding helps healthcare professionals prescribe appropriately based on individual patient needs.
Comparing Treatment Options: Value and Efficacy
Many patients ask whether generic sildenafil differs from branded Viagra. From a clinical perspective, both contain identical active ingredients and demonstrate equivalent bioavailability. The primary difference lies in cost - generic sildenafil typically costs significantly less whilst maintaining the same therapeutic effect. At EverydayMeds, we offer both options, allowing patients to choose based on personal preference and budget considerations following clinical assessment.
BNF Dosing Guidelines and Clinical Practice
The BNF recommends starting sildenafil at 50mg, taken approximately one hour before sexual activity. Based on individual response and tolerability, dosing may be adjusted to 25mg or increased to 100mg. Our UK-licensed prescribers follow these guidelines strictly, ensuring patients receive appropriate dosing recommendations. The maximum frequency remains once daily, with effects typically lasting 4-6 hours - though this refers to the medication's presence, not continuous erection.
Safety Considerations and Clinical Assessment
Healthcare professionals emphasise that sildenafil requires careful patient assessment before prescribing. The BNF highlights important contraindications, particularly concurrent nitrate use, which creates dangerous hypotensive effects. Our clinical team evaluates cardiovascular health, current medications, and medical history during consultation. This thorough approach ensures treatment suitability and identifies any potential drug interactions before prescribing either branded or generic sildenafil.
Clinical Efficacy and Patient Outcomes
Clinical studies supporting BNF recommendations demonstrate sildenafil's effectiveness in approximately 70-80% of men with erectile dysfunction across various underlying causes. Response rates may vary based on factors including diabetes, cardiovascular disease, or psychological components. Our healthcare professionals discuss realistic expectations during consultation, helping patients understand how sildenafil might work in their specific circumstances. Both generic sildenafil and branded Viagra demonstrate identical clinical outcomes in peer-reviewed studies.
